ARTICLE | Company News
Management tracks: Medicines Co., Mallinckrodt, ArQule
March 19, 2019 10:38 PM UTC
The Medicines Co. (NASDAQ:MDCO) terminated the employment of Christopher Cox, EVP and chief corporate development officer, effective March 15. Details were not disclosed.
Mallinckrodt plc (NYSE:MNK) hired Bryan Reasons as CFO. He will succeed interim CFO George Kegler. Reasons was SVP and CFO at Impax Laboratories Inc. prior to its merger with Amneal Pharmaceuticals Inc. (NYSE:AMRX)...